bumetanide has been researched along with Prostatic Hyperplasia in 1 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten males had a history of prostatic hypertrophy and in these patients treatment with bumetanide was not beneficial." | 2.66 | Prophylactic treatment of adult nocturia with bumetanide. ( Johansen, PB; Pedersen, PA, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pedersen, PA | 1 |
| Johansen, PB | 1 |
1 trial available for bumetanide and Prostatic Hyperplasia
| Article | Year |
|---|---|
Prophylactic treatment of adult nocturia with bumetanide.
Topics: Aged; Bumetanide; Circadian Rhythm; Clinical Trials as Topic; Diuretics; Double-Blind Method; Enures | 1988 |